Stockscreener 앱 받기
1.59
0.63%
0.01
시간 외 거래:
1.55
-0.04
-2.52%
전일 마감가:
$1.58
열려 있는:
$1.6
하루 거래량:
25,684
Relative Volume:
0.03
시가총액:
$184.48M
수익:
$1.93M
순이익/손실:
$-3.10M
주가수익비율:
-0.0972
EPS:
-16.3657
순현금흐름:
$-1.93M
1주 성능:
-6.47%
1개월 성능:
-10.17%
6개월 성능:
-48.34%
1년 성능:
-80.12%
1일 변동 폭
$1.57
$1.605
1주일 범위
$1.50
$1.73
52주 변동 폭
$0.95
$8.64
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
명칭
China Sxt Pharmaceuticals Inc
전화
-
주소
-
SXTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
1.59 | 174.04M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
China Sxt Pharmaceuticals Inc 주식(SXTC)의 최신 뉴스
Is China SXT Pharmaceuticals Inc. stock entering bullish territoryChart-Based Entry Confirmation for Beginners - Newser
Chart overlay techniques for tracking China SXT Pharmaceuticals Inc.Entry Optimization Tool with Screener Logic - Newser
Is China SXT Pharmaceuticals Inc. a momentum stockFast Payout Trading Plans - newsyoung.net
China SXT Pharmaceuticals Inc. stock momentum explainedMonthly Trade Result and Signal Summary - Newser
How to monitor China SXT Pharmaceuticals Inc. with trend dashboardsWealth Accumulation Outlook for Safe Investors - Newser
Using data models to predict China SXT Pharmaceuticals Inc. stock movementSwing Trade Planning with Consistent Setup - Newser
Statistical indicators supporting China SXT Pharmaceuticals Inc.’s strengthFree Entry Plan for Oversold Reversal Stocks - Newser
Ranking China SXT Pharmaceuticals Inc. among high performing stocks via toolsLong-Term Safety Investment Analysis Report - Newser
How to build a dashboard for China SXT Pharmaceuticals Inc. stockFree Buy Alerts With Low Risk Confirmation - Newser
Does China SXT Pharmaceuticals Inc. qualify in momentum factor screeningSafe and Scalable Return Strategy Blueprint - Newser
Key External Factors That Drive China SXT Pharmaceuticals Inc. Stock Price MovementsSector Rotation and Stock Opportunity Analysis - Newser
How sentiment analysis helps forecast China SXT Pharmaceuticals Inc.Free Risk Managed Intraday Trade Alerts - Newser
Custom strategy builders for tracking China SXT Pharmaceuticals Inc.AI Stock Movement Forecast with Accuracy - Newser
Heatmap analysis for China SXT Pharmaceuticals Inc. and competitorsExit Strategy Guide With Risk Control Plan - Newser
China SXT Pharmaceuticals Inc. stock outlook for YEARReal Stock Picks With Setup Verification - Newser
Is it too late to sell China SXT Pharmaceuticals Inc.Quick Profit Setup with Signal Forecast - Newser
What makes China SXT Pharmaceuticals Inc. stock price move sharplyFree Trade Ready Stock Watch for Short Term - Newser
What Fibonacci levels say about China SXT Pharmaceuticals Inc. reboundFree Fundamental + Technical Hybrid Stock Tips - Newser
Tools to assess China SXT Pharmaceuticals Inc.’s risk profileStrong Buy Opportunity with Volume Support - Newser
Combining machine learning predictions for China SXT Pharmaceuticals Inc.Real-Time Equity Price Action Analysis - Newser
China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Rating Upgraded by Wall Street Zen - Defense World
How strong is China SXT Pharmaceuticals Inc. company’s balance sheetIdentify winners with top-tier analysis - Jammu Links News
What analysts say about China SXT Pharmaceuticals Inc. stockPhenomenal returns - Jammu Links News
How does China SXT Pharmaceuticals Inc. generate profit in a changing economyMassive portfolio appreciation - Jammu Links News
Is China SXT Pharmaceuticals Inc. a good long term investmentUnlock high-yield investment opportunities - Jammu Links News
What drives China SXT Pharmaceuticals Inc. stock priceAchieve breakthrough financial results - Jammu Links News
When is China SXT Pharmaceuticals Inc. stock expected to show significant growthInvest in stocks with strong fundamentals - Jammu Links News
Why is China SXT Pharmaceuticals Inc. stock attracting strong analyst attentionMaximize returns with strategic trading plans - Jammu Links News
Is it the right time to buy China SXT Pharmaceuticals Inc. stockInvest smarter with comprehensive market analysis - Jammu Links News
How high can China SXT Pharmaceuticals Inc. stock price go in 2025Stock Market Trend and Pattern Analysis - Newser
What is China SXT Pharmaceuticals Inc. company’s growth strategyAchieve consistent profits with proven methods - Jammu Links News
What institutional investors are buying China SXT Pharmaceuticals Inc. stockConsistent high-performance stocks - Jammu Links News
What is the risk reward ratio of investing in China SXT Pharmaceuticals Inc. stock - Jammu Links News
Does China SXT Pharmaceuticals Inc. stock perform well during market downturnsMaximize gains with data-driven trading alerts - Jammu Links News
China SXT Pharmaceuticals Full Year 2025 Earnings: US$2.32 loss per share (vs US$28.58 loss in FY 2024) - Yahoo Finance
China SXT Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingVolume Confirmed Setup with Entry Confidence - Newser
China Sxt Pharmaceuticals Inc (SXTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):